The CDC and the FDA lifted the pause in vaccinations with Johnson & Johnson’s/Janssen COVID-19 vaccine. This action was based on thorough review of all available data as of April 21, 2021, concluding that the Johnson & Johnson COVID-19 vaccine’s known and potential benefits outweigh its known and potential risks. The federal agencies do recommend women younger than 50 years old be aware of a rare and severe type of blood clot combined with low blood platelet levels.
“These adverse events are extremely rare, affecting approximately four to 10 out of every 1,000,000 people vaccinated with J&J, ”clarifies Millennium’s Chief Medical Officer Alejandro Perez-Trepichio.
Currently, the observation period is recommended to be up to three weeks following the J&J vaccine administration (generally six to 13 days post vaccination.) Patients should immediately contact your Millennium healthcare provider or regular provider if you develop any of the following symptoms within three weeks after receiving the J&J vaccine:
- Shortness of breath
- Chest pain
- Leg swelling
- Persistent abdominal pain
- Severe or persistent headaches or blurred vision
Easy bruising or tiny blood spots under the skin beyond the site of the injection
In line with the CDC and FDA recommendations, Millennium will immediately resume administering the J&J vaccine as supplies permit. If you are a woman younger than 50 years old, the CDC reminds you that other COVID-19 vaccine options are available. Millennium will continue administering the Moderna vaccine without interruption.
“We continue to strongly urge all of our patients to consider getting vaccinated through Millennium or any other reliable vaccination site, as this remains crucial in achieving herd immunity and potentially ending the Pandemic once and for all,” adds Dr. Perez-Trepichio.
CDC and FDA will continue to monitor the safety of all COVID-19 vaccines, and Millennium will update you on any changes.
Learn more about available COVID-19 vaccines here.